Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Theriva Biologics Inc.

    AMEX: TOVX · Real-Time Price · USD
    0.49
    -0.04 (-7.55%)
    At close: Jun 12, 2025, 3:59 PM

    Theriva Biologics Statistics

    Share Statistics

    Theriva Biologics has 8.19M shares outstanding. The number of shares has increased by -83.9% in one year.

    Shares Outstanding

    n/a
    		 8.19M

    Shares Change (YoY)

    n/a
    		 -83.9%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 8.1M

    Failed to Deliver (FTD) Shares

    n/a
    		 43,239

    FTD / Avg. Volume

    n/a
    		 3.21%

    Short Selling Information

    The latest short interest is 172.67K, so 2.11% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 172.67K

    Short % of Shares Out

    n/a
    		 2.11%

    Short % of Float

    n/a
    		 2.11%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.09 and the forward PE ratio is -0.08. Theriva Biologics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.09

    Forward PE

    n/a
    		 -0.08

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.12

    P/FCF Ratio

    n/a
    		 -0.14

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Theriva Biologics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.08.

    Current Ratio

    n/a
    		 2.15

    Quick Ratio

    n/a
    		 2.15

    Debt / Equity

    n/a
    		 0.08

    Debt / EBITDA

    n/a
    		 -0.06

    Debt / FCF

    n/a
    		 -0.09

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,282,650

    Employee Count

    n/a
    		 20

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -92.01% in the last 52 weeks. The beta is 0.83, so Theriva Biologics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.83

    52-Week Price Change

    n/a
    		 -92.01%

    50-Day Moving Average

    n/a
    		 0.9

    200-Day Moving Average

    n/a
    		 1.57

    Relative Strength Index (RSI)

    n/a
    		 39.22

    Average Volume (20 Days)

    n/a
    		 1,345,547

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -26.35M

    Net Income

    n/a
    		 -25.65M

    EBITDA

    n/a
    		 -26.35M

    EBIT

    n/a
    		 -25.65M

    Earnings Per Share (EPS)

    n/a
    		 -19.03
    Full Income Statement

    Balance Sheet

    The company has 11.61M in cash and 1.56M in debt, giving a net cash position of 10.04M.

    Cash & Cash Equivalents

    n/a
    		 11.61M

    Total Debt

    n/a
    		 1.56M

    Net Cash

    n/a
    		 10.04M

    Retained Earnings

    n/a
    		 -334.97M

    Total Assets

    n/a
    		 32.16M

    Working Capital

    n/a
    		 4.33M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -16.94M and capital expenditures -1K, giving a free cash flow of -16.94M.

    Operating Cash Flow

    n/a
    		 -16.94M

    Capital Expenditures

    n/a
    		 -1K

    Free Cash Flow

    n/a
    		 -16.94M

    FCF Per Share

    n/a
    		 -12.56
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    TOVX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TOVX is $6, which is 1150% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $6

    Price Target Difference

    n/a
    		 1150%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 26, 2024. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Aug 26, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 -16.36

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist